CarMax reportedly reacts swiftly to earnings miss with a $1.25B bond sale, aiming to address investor concerns. Mitsubishi UFJ Financial Group oversees the deal, anticipated to rise to $1.6 billion.

Eliem Therapeutics will acquire Tenet Medicines, focusing on advancing TNT119, an anti-CD19 antibody for autoimmune diseases. Strategic alternatives explored. $120 million private placement. Acquisition expected mid-2024.

Velo3D shares drop after announcing $12 million public offering of stock and warrants. To be used for working capital and debt repayment.

In a new regulatory filing, SoundHound said it entered into an equity distribution agreement in which the company may offer and sell up to $150 million of its Class A common stock from time to time in an at-the-market equity program.

Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates, adverse events, and future plans. Stay updated on Protara Therapeutics' advancements in cancer therapy and FDA alignment for Choline Chloride.

Signet Jewelers Ltd (NYSE:SIG) and Leonard Green & Partners, L.P. announce a significant strategic move, amending Series A Convertible Preference Shares to net share settlement and repurchasing half of the Preferred Shares. CEO Virginia C. Drosos emphasizes the company's robust performance, marked by double-digit revenue growth, enhanced gross margins, and a substantial increase in non-GAAP diluted earnings per share, along with significant returns to shareholders.

Surrozen engages in a private placement, aiming to raise approximately $192.5 million in gross proceeds. Updates on SZN-043 Phase 1a trial reveal promising safety, tolerability, and effects on liver function.

Discover OrganiGram's strategic $25M public offering aimed at fueling growth and shaping the future of the cannabis industry.

AMC shares are trading lower Thursday after the company announced an offering. The company entered into an equity distribution agreement to sell up to $250 million of its common stock from time to time in an at-the-market offering.

Bowman Consulting prices public offering at $34.00 per share, 14% below March 26 closing. Company to sell 1.32 million shares, with additional option. Gross proceeds estimated at $45.0 million to be used for expansion, acquisitions, and debt repayment.

Renault SA (OTC: RNLSY) revealed a second transaction with its intention to sell to Nissan Motor up to 100.24 million Nissan shares, representing approximately 2.5% of Nissan's capital. This transaction follows the sale of Nissan shares on December 13, 2023.

Plug Power issues $140.396 million in convertible senior notes, with $58.5 million of 2025 notes remaining outstanding.

After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of its common stock. The company also intends to grant the underwriters a 30-day window to purchase up to an additional 15% of the shares in the public offering.